SIMCERE PHARMA (02096) spent 10.1667 million Hong Kong dollars to repurchase 1.49 million shares on November 18th.
Sinopharm (02096) announced that on November 18, 2024, the company invested 1016.67 million...
SIMCERE PHARMA (02096) announced that on November 18, 2024, the company repurchased 1.49 million shares at a cost of 10.167 million Hong Kong dollars. The repurchase price was between 6.71 and 6.98 Hong Kong dollars per share.
Related Articles
Title: New Stock Preview | Can Shenzhen Longsys Electronics cross the industry volatility in the new cycle driven by AI storage?
"Standing in the light", Broadcom Inc. (AVGO.US) solidifies its cash flow base with a $30 billion debt repurchase. The bullish market logic of "optical interconnect + AI ASIC" computing power is further strengthened.
Starbucks Corporation (SBUX.US) increases its investment in the Indian market: Plans to open one hundred new stores every year, CEO says "Expansion is a priority over profitability"
Title: New Stock Preview | Can Shenzhen Longsys Electronics cross the industry volatility in the new cycle driven by AI storage?
"Standing in the light", Broadcom Inc. (AVGO.US) solidifies its cash flow base with a $30 billion debt repurchase. The bullish market logic of "optical interconnect + AI ASIC" computing power is further strengthened.
Starbucks Corporation (SBUX.US) increases its investment in the Indian market: Plans to open one hundred new stores every year, CEO says "Expansion is a priority over profitability"
RECOMMEND
